Perhaps we are looking at the wrong thing the wrong way in the wrong sample at the wrong time-or some combination of the above. Maybe it is time to begin anew.
Lundell (8), of the National Bureau of Standards, 58 years ago wrote a somewhat critical commentary, "The Chemical Analysis of Things As They Are," because so many talks and articles on analytical subjects dealt with "The Chemical Analysis of Things As They Are Not." Although Lundell was not discussing phospholipids, the arguments presented are quite applicable to the subject at hand. So many of the reports I have read on phospholipid analysis deal with things as they are not. We tend to overlook sample preparation and get right to the final measurement part of the procedure, treating the sample as if it were a solution of pure material. Why? Freer and Statland warned us that it is not a simple pure solution. As a profession, we take painstaking care in sample preparation for most other tests; why then do we allow such controversy for the evaluation of fetal lung maturity?
How can we continue to ignore these factors, given the dearth of consensus in the field? The very first step in many procedures is centrifugation of the sample, yet this is also one of the most controversial steps. Why should it remain controversial when we have had nearly a quarter of a century to resolve this issue?
I do not consider it likely that within the next decade we will all be using fast atom bombardment mass spectrometry to analyze amniotic fluid phospholipids.
In the face of the existing methodological controversy and fiscal restraints, some things are just not going to change that quickly. However, perhaps fast atom bombardment mass spectrometry is the analytical tool that some of the members of our profession could use to best resolve all of those controversial steps to which we have been alerted.
If so, then for the first time since the inception of amniotic fluid analysis we can, "at least...
begin to end the often heated discourse between laboratorian and clinician ..." (3) . And perhaps for the first time we will be able to view analysis for amniotic fluid phospholipids in terms of the chemical analysis of things as they are.
